Strategy to find molecular signatures in a small series of rare cancers: Validation for Radiation-Induced breast and thyroid tumors

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Ugolin, Nicolas ^a   Ory, Catherine ^a   Lefevre, Emilie ^a   Benhabiles, Nora ^a   Hofman, Paul ^b,c,d   Schlumberger, Martin ^e   Chevillard, Sylvie ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^b INSERM   (France)

^c UNIVERSITÉ CÔTE D'AZUR   (France)

^d PASTEUR HOSPITAL   (France)

^e INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME;

ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER GENETICS; CANCER STAGING; CHERNOBYL ACCIDENT; CONTROLLED STUDY; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LEARNING ALGORITHM; MICROARRAY ANALYSIS; PREDICTION; PRINCIPAL COMPONENT ANALYSIS; RADIATION INDUCED NEOPLASM; SCORING SYSTEM; STANDARDIZATION; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; VALIDATION STUDY; ADENOMA; BREAST TUMOR; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; REPRODUCIBILITY; THYROID TUMOR;

ADENOMA; BREAST NEOPLASMS; CHERNOBYL NUCLEAR ACCIDENT; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS, RADIATION-INDUCED; PRINCIPAL COMPONENT ANALYSIS; REPRODUCIBILITY OF RESULTS; THYROID NEOPLASMS;

EID: 80051608665     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023581     Document Type: Article

References (36)

1. Cuperlovic-Culf M, Belacel N, Ouellette RJ, (2005) Determination of tumour marker genes from gene expression data. Drug Discov Today 10: 429-437.
2. Nannini M, Pantaleo MA, Maleddu A, Astolfi A, Formica S, et al. (2009) Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives. Cancer Treat Rev 35: 201-209.
3. van der Vegt B, de Bock GH, Hollema H, Wesseling J, (2009) Microarray methods to identify factors determining breast cancer progression: potentials, limitations, and challenges. Crit Rev Oncol Hematol 70: 1-11.
4. Alexe G, Dalgin GS, Scanfeld D, Tamayo P, Mesirov JP, et al. (2007) Breast cancer stratification from analysis of micro-array data of micro-dissected specimens. Genome Inform 18: 130-140.
5. Dudoit S, Fridlyand J, Speed TP, (2002) Comparison of discrimination methods for the classification of tumors using gene expression data. J Am Stat Assoc 97: 77-87.
6. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, et al. (1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286: 531-537.
7. Tusher VG, Tibshirani R, Chu G, (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.
8. Chevillard S, Ugolin N, Vielh P, Ory K, Levalois C, et al. (2004) Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications. Clin Cancer Res 10: 6586-6597.
9. Ressom HW, Varghese RS, Zhang Z, Xuan J, Clarke R, (2008) Classification algorithms for phenotype prediction in genomics and proteomics. Front Biosci 13: 691-708.
10. Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang CH, et al. (2001) Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci U S A 98: 15149-15154.
11. Detours V, Wattel S, Venet D, Hutsebaut N, Bogdanova T, et al. (2005) Absence of a specific radiation signature in post-Chernobyl thyroid cancers. Br J Cancer 92: 1545-1552.
12. Detours V, Delys L, Libert F, Weiss Solis D, Bogdanova T, et al. (2007) Genome-wide gene expression profiling suggests distinct radiation susceptibilities in sporadic and post-Chernobyl papillary thyroid cancers. Br J Cancer 97: 818-825.
13. Broeks A, Braaf LM, Wessels LF, van de Vijver M, De Bruin ML, et al. (2010) Radiation-associated breast tumors display a distinct gene expression profile. Int J Radiat Oncol Biol Phys 76: 540-547.
14. Zilliox MJ, Irizarry RA, (2007) A gene expression bar code for microarray data. Nat Methods 4: 911-913.
15. Geman D, d'Avignon C, Naiman DQ, Winslow RL, (2004) Classifying gene expression profiles from pairwise mRNA comparisons. Stat Appl Genet Mol Biol 3: Article19.
16. Ghosh D, (2002) Singular value decomposition regression models for classification of tumors from microarray experiments. Pac Symp Biocomput pp. 18-29.
17. Ernst MD, (2004) Permutation Methods: A Basis for Exact Inference. Statist Sci 19: 676-685.
18. Amundson SA, Do KT, Vinikoor L, Koch-Paiz CA, Bittner ML, et al. (2005) Stress-specific signatures: expression profiling of p53 wild-type and-null human cells. Oncogene 24: 4572-4579.
19. Fujarewicz K, Jarzab M, Eszlinger M, Krohn K, Paschke R, et al. (2007) A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping. Endocr Relat Cancer 14: 809-826.
20. Efron B, (1979) Bootstrap Methods: Another Look at the Jackknife. Ann Statist 7: 1-26.
21. Efron B, Tibshirani RJ, (1993) An Introduction to the Bootstrap (Monographs on Statistics and Applied Probability) Chapman & Hall/CRC.
22. Manly B, (2006) Randomization, bootstrap and Monte Carlo methods in biology, third Edition Chapman and Hall/CRC.
23. Huang Y, Prasad M, Lemon WJ, Hampel H, Wright FA, et al. (2001) Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc Natl Acad Sci U S A 98: 15044-15049.
24. Jarzab B, Wiench M, Fujarewicz K, Simek K, Jarzab M, et al. (2005) Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications. Cancer Res 65: 1587-1597.
25. Griffith OL, Melck A, Jones SJ, Wiseman SM, (2006) Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers. J Clin Oncol 24: 5043-5051.
26. Ntzani EE, Ioannidis JP, (2003) Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment. Lancet 362: 1439-1444.
27. Tothill RW, Kowalczyk A, Rischin D, Bousioutas A, Haviv I, et al. (2005) An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin. Cancer Res 65: 4031-4040.
28. Yang XJ, Sugimura J, Schafernak KT, Tretiakova MS, Han M, et al. (2006) Classification of renal neoplasms based on molecular signatures. J Urol 175: 2302-2306.
29. McCall MN, Uppal K, Jaffee HA, Zilliox MJ, Irizarry RA, (2011) The Gene Expression Barcode: leveraging public data repositories to begin cataloging the human and murine transcriptomes. Nucleic Acids Res 39: D1011-1015.
30. Hofman P, (2006) (The CHU-CRLCC-UNSA tumour/tissue bank of the Nice area). Med Sci (Paris) 22 Spec No 1: 21-25.
31. Ory C, Ugolin N, Levalois C, Lacroix L, Caillou B, et al. (2011) Gene expression signature discriminates sporadic from post-radiotherapy-induced thyroid tumors. Endocr Relat Cancer 18: 193-206.
32. Daino K, Ugolin N, Altmeyer-Morel S, Guilly MN, Chevillard S, (2009) Gene expression profiling of alpha-radiation-induced rat osteosarcomas: Identification of dysregulated genes involved in radiation-induced tumorigenesis of bone. Int J Cancer.
33. Le Brigand K, Russell R, Moreilhon C, Rouillard JM, Jost B, et al. (2006) An open-access long oligonucleotide microarray resource for analysis of the human and mouse transcriptomes. Nucleic Acids Res 34: e87.
34. Chiappetta P, Roubaud MC, Torresani B, (2004) Blind source separation and the analysis of microarray data. J Comput Biol 11: 1090-1109.
35. Kong W, Vanderburg CR, Gunshin H, Rogers JT, Huang X, (2008) A review of independent component analysis application to microarray gene expression data. Biotechniques 45: 501-520.
36. Hastie T, Tibshirani R, Eisen MB, Alizadeh A, Levy R, et al. (2000) 'Gene shaving' as a method for identifying distinct sets of genes with similar expression patterns. Genome Biol 1 (2): RESEARCH0003.